午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

{6-methyl-[1,2,4]triazolo[4,3-a]pyridin-3-yl}methanamine dihydrochloride

{6-methyl-[1,2,4]triazolo[4,3-a]pyridin-3-yl}methanamine dihydrochloride Struktur
1909306-24-6
CAS-Nr.
1909306-24-6
Englisch Name:
{6-methyl-[1,2,4]triazolo[4,3-a]pyridin-3-yl}methanamine dihydrochloride
Synonyma:
{6-methyl-[1,2,4]triazolo[4,3-a]pyridin-3-yl}methanamine dihydrochloride
CBNumber:
CB84662693
Summenformel:
C8H11ClN4
Molgewicht:
198.65
MOL-Datei:
1909306-24-6.mol

{6-methyl-[1,2,4]triazolo[4,3-a]pyridin-3-yl}methanamine dihydrochloride Eigenschaften

Sicherheit

{6-methyl-[1,2,4]triazolo[4,3-a]pyridin-3-yl}methanamine dihydrochloride Chemische Eigenschaften,Einsatz,Produktion Methoden

{6-methyl-[1,2,4]triazolo[4,3-a]pyridin-3-yl}methanamine dihydrochloride Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

{6-methyl-[1,2,4]triazolo[4,3-a]pyridin-3-yl}methanamine dihydrochloride Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 9)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Capot Chemical Co.,Ltd. 		+86-（0）57185586718 +86-13336195806
 sales@capot.com China 29730 60
Coresyn Pharmatech Co., Ltd. 		+86-571-86626709 +86-18157142896
 cbc@coresyn.com China 9984 58
Shanghai Chenghe Medical Technology Co. Ltd. 18601603956
 18601603956@163.com China 1158 58
Shanghai Haohong Pharmaceutical Co., Ltd. 400-4008210725 4008210725
 malulu@leyan.com China 54987 58
Hangzhou Laisheng Biotechnology Co., LTD 13456210265
 3578746376@qq.com China 843 58
Bide Pharmatech Ltd. 400-1647117 13681763483
 product02@bidepharm.com China 62072 58
Bide Pharmatech Ltd. 400-6005915
sales@picasso-e.com China 39665 58
Shanghai Yanbang Pharmaceutical Technology Co., Ltd 15618536883
 1228181347@qq.com China 7988 58
Jiangsu Aikon Biopharmaceutical R&D Co.,Ltd 025-58851090 13915962545
 2881759498@qq.com China 13082 58
  • {6-methyl-[1,2,4]triazolo[4,3-a]pyridin-3-yl}methanamine dihydrochloride
  • 1909306-24-6
Copyright 2019 ? ChemicalBook. All rights reserved